Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
World J Clin Cases ; 11(14): 3323-3329, 2023 May 16.
Article in English | MEDLINE | ID: mdl-37274033

ABSTRACT

BACKGROUND: Left ventricular thrombus is a rare condition, for which appropriate treatments are not extensively studied. Although it can be treated by thrombectomy, such surgery can be difficult and risky, and not every patient can tolerate the surgery. CASE SUMMARY: We report a case of a middle-aged man receiving veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for acute myocardial infarction who developed left ventricular thrombus despite systemic anticoagulation. After systemic thrombolysis with urokinase, the left ventricular thrombus disappeared, ECMO was successfully withdrawn 9 days later, and the patient recovered and was discharged from hospital. CONCLUSION: Systemic thrombolysis is a treatment option for left ventricular thrombus in addition to anticoagulation and thrombectomy.

2.
Kidney Blood Press Res ; 47(10): 616-630, 2022.
Article in English | MEDLINE | ID: mdl-36130530

ABSTRACT

INTRODUCTION: Sepsis is a primary cause of death in critically ill patients and is characterized by multiple organ dysfunction, including sepsis-induced acute kidney injury (AKI), which contributes to high mortality in sepsis. However, its pathophysiological mechanisms remain unclear. The kidney has one of the richest and most diversified endothelial cell populations in the body. This study was designed to investigate the effects of endothelial dysfunction in sepsis-induced AKI and explore possible intervention measures to offer new insight into the pathogenesis and treatment of sepsis-induced AKI. METHODS: The circulating levels of endothelial adhesion molecules were detected in patients with sepsis and healthy controls to observe the role of endothelial damage in sepsis and sepsis-induced AKI. A murine sepsis model induced by cecal ligation and perforation was pretreated with a phosphoinositide 3-kinase gamma (PI3Kγ) inhibitor (CZC24832), and survival, kidney damage, and renal endothelial injury were assessed by pathological examination, immunohistochemistry, quantitative polymerase chain reaction, and Western blotting. Lipopolysaccharides and CZC24832 were administered to human umbilical vein endothelial cells in vitro, and endothelial cell function and the expression of adhesion molecules were evaluated. RESULTS: Endothelial damage was more serious in sepsis-induced AKI than that in non-AKI, and the inhibition of PI3Kγ alleviates renal endothelial injury in a murine sepsis model, protecting endothelial cell function and repairing endothelial cell injury through the Akt signaling pathway. CONCLUSIONS: In this study, endothelial cell dysfunction plays an important role in sepsis-induced AKI, and the inhibition of PI3Kγ alleviates endothelial cell injury in sepsis-induced AKI through the PI3Kγ/Akt pathway, providing novel targets for treating sepsis and related kidney injury.


Subject(s)
Acute Kidney Injury , Sepsis , Humans , Mice , Animals , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Phosphatidylinositol 3-Kinase , Acute Kidney Injury/pathology , Sepsis/complications , Sepsis/pathology , Signal Transduction , Kidney/pathology , Human Umbilical Vein Endothelial Cells/metabolism , Human Umbilical Vein Endothelial Cells/pathology
3.
Inflamm Bowel Dis ; 20(8): 1407-15, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24983982

ABSTRACT

BACKGROUND: Fecal calprotectin (FC) is a promising biomarker for diagnosis of inflammatory bowel disease (IBD). However, the utility of FC for assessment of IBD activity has yet to be clearly demonstrated. The aim of our study was to evaluate the diagnostic accuracy of FC for differentiating between patients with active IBD and those in remission. METHODS: We systematically searched the databases Medline, Web of Science, Cochrane Library, and EMBASE for eligible studies from December 2013 or earlier that evaluated activity in ulcerative colitis (UC) and Crohn's disease (CD). A hierarchical summary receiver operating characteristic model was performed to calculate the area under the curve to evaluate the overall diagnostic accuracy. The sensitivities and specificities of each commonly applied cutoff value were pooled using a random effects model. RESULTS: We included 13 studies (744 patients with UC and 727 with CD) in the final analysis. The area under the curve values were 0.89 (95% confidence interval, 0.86-0.92), 0.93 (0.89-0.97), and 0.88 (0.83-0.93) in the IBD, UC, and CD groups, respectively. For the IBD group at a cutoff value of 50 µg/g, the pooled sensitivity was 0.92 (0.90-0.94) and specificity 0.60 (0.52-0.67). For a cutoff value at 100 µg/g, the pooled sensitivity was 0.84 (0.80-0.88) and specificity was 0.66 (0.59-0.73). For a cutoff value at 250 µg/g, the pooled sensitivity was 0.80 (0.76-0.84) and specificity was 0.82 (0.77-0.86). CONCLUSIONS: The FC test is a reliable marker for assessing IBD disease activity and may have greater ability to evaluate disease activity in UC than CD.


Subject(s)
Biomarkers/analysis , Inflammatory Bowel Diseases/diagnosis , Leukocyte L1 Antigen Complex/analysis , Humans , Prognosis , ROC Curve , Severity of Illness Index
4.
Zhongguo Zhong Yao Za Zhi ; 30(24): 1927-9, 2005 Dec.
Article in Chinese | MEDLINE | ID: mdl-16494026

ABSTRACT

OBJECTIVE: To study the chemical constituents in roots and rhizomes of ligularia duciforms. METHOD: The compounds were isolated by column chromatography, the structures were identified by physicochemical properties and spectral analysis. RESULT: Six compounds were isolated and identified as caffeic acid (I), (E)-docosyl-3, 4-dihydroxycinnamate (II), (E)-docosyl 3-methoxy-4-hydroxyferulate (III, beta-amyrone (IV), beta-sitosterol (V), and daucosterol (VI). CONCLUSION: All the compound were isolated for the first time from the plant, and the compound II and IV were isolated firstly from the genus Ligularia.


Subject(s)
Asteraceae/chemistry , Cinnamates/isolation & purification , Coumaric Acids/isolation & purification , Plants, Medicinal/chemistry , Caffeic Acids/chemistry , Caffeic Acids/isolation & purification , Cinnamates/chemistry , Coumaric Acids/chemistry , Plant Roots/chemistry , Rhizome/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...